Short Communication
References
|
Abdollahi M, Farshchi A, Nikfar S, Seyedifar M (2013). Effect of chromium on glucose and lipid profiles in patients with type 2 diabetes; a meta-analysis review of randomized trials. J. Pharm. Pharm. Sci. 16:99-114. Pubmed |
||||
|
Anderson RA (1998a). Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17:548-555. Crossref |
||||
|
Anderson RA (1998b). Recent advances in the clinical and biochemical manifestation of chromium deficiency in human and animal nutrition. J. Trace Elem. Exp. Med. 11:241-50. Crossref |
||||
|
Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, Feng J (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46:1786-1791. Crossref |
||||
|
Bahijiri SM, Mira SA, Mufti AM, Ajabnoor MA (2000). The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med. J. 21:831-837. Pubmed |
||||
|
Cefalu WT, Hu FB (2004). Role of chromium in human health and in diabetes. Diabetes Care 27:2741-2751. Crossref |
||||
| DiSilvestro RA (2005). Handbook of Minerals as Nutritional Supplements, CRC Press, Boca Raton. p. 272. | ||||
| Evans GW (1989). The effect of chromium picolinate on insulin controlled parameters in humans. Int. J. Biosci. Med. Res. 11:163-180. | ||||
|
Geohas J, Daly A, Juturu V, Finch M, Komorowski JR (2007). Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: A placebo-controlled, double-blinded, randomized clinical trial. Am. J. Med. Sci. 333:145-53. Crossref |
||||
|
Heimbach JT, Anderson RA (2005). Chromium: Recent studies regarding nutritional roles and safety. Nutr. Today 40:2-8. Crossref |
||||
| Institute of Medicine, Food and Nutrition Board (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. National Academy Press, Washington, DC. p 773. | ||||
|
Lee NA, Reasner CA (1994). Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17:1449-1452. Crossref |
||||
|
Masharani U, Gjerde C, McCoy S, Maddux BA, Hessler D, Goldfine ID, Youngren J (2012). Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity. BMC Endocr. Disord. 12:31. Crossref |
||||
|
Mertz W (1993). Chromium in human nutrition: A review. J. Nutr. 123:626-633. Pubmed |
||||
|
Morris BW, MacNeil S, Hardisty CA, Heller S, Burgin C, Gray TA (1999). Chromium homeostasis in patients with type II (NIDDM) diabetes. J. Trace Elem. Med. Biol. 13:57-61. Crossref |
||||
| National Research Council, Food and Nutrition Board (1989). Recommended Dietary Allowances, 10th Edition. National Academy Press, Washington. p. 285. | ||||
|
Pei D, Hsieh CH, Hung YJ, Li JC, Lee CH, Kuo SW (2006). The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Metabolism 55:923-927. Crossref |
||||
|
Preuss HG, Wallerstedt D, Talpur N, Tutuncuoglu SO, Echard B, Myers A, Bui M, Bagchi D (2000). Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J. Med. 31:227-246. Pubmed |
||||
|
Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C, Habot B (2004). Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int. J. Vitam. Nutr. Res. 74:178-82. Crossref |
||||
|
Uusitupa MI, Kumpulainen JT, Voutilainen E, Hersio K, Sarlund H, Pyörälä KP, Koivistoinen PE, LehtoEvans JT (1983). Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am. J. Clin. Nutr. 38:404-410. Pubmed |
||||
|
Vijayaraghavan K (2010). Treatment of dyslipidemia in patients with type 2 diabetes. Lipids Health Dis. 9:144. Crossref |
||||
|
Vincent JB (2013). Chromium: Is it essential, pharmacologically relevant, or toxic? Met. Ions Life Sci. 13:171-198. Crossref |
||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
